The arrival of Retatrutide ZPHC, at a dosage of 120mg, is creating considerable interest within the weight loss community. This groundbreaking dual GIP and GLP-1 agonist medication suggests to offer impressive improvements in body reduction compared to current therapies. Early patient studies have s